Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgac734 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Natasha M Appelman-Dijkstra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Bone Quality Leiden University Medical Center: Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Cente…. Hauptthemen laut MEDLINE: Hypercalcemia, Parathyroid Diseases, Pregnancy Complications, Hypoparathyroidism. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Taking care of patients with parathyroid disorders during pregnancy requires consideration of the physiological fundamental changes in bone and mineral metabolism occurring in these women. Diagnostic and therapeutic procedures regarding primary hyperparathyroidism (PHPT) and hypoparathyroidism significantly differ from the nonpregnant population. PHPT should preferably be cured by parathyroidectomy before pregnancy since in women with hypercalcemic PHPT, maternal and fetal pregnancy complications seem to increase according to the degree of hypercalcemia. Parathyroidectomy, if needed during pregnancy, is preferentially performed in the second trimester. Conservative treatment is recommended for milder cases and is mainly restricted to hydration, with only limited evidence regarding drug treatment. Women with hypoparathyroidism can be informed that there are no major concerns regarding disease-associated infertility and that the risk of pregnancy complications is low if the disease is properly managed. Regular active surveillance is recommended, as requirements for calcium and active vitamin D may change during the course of pregnancy in either direction, with an overall trend for rather reduced doses. Any woman suffering from parathyroid disorders during pregnancy requires further surveillance in the postpartum period and during lactation, as there is an increased risk of hypercalcemia after delivery. Newborns of mothers with parathyroid diseases should, depending on disease severity, be carefully monitored for calcium levels in the first days (to weeks) after delivery since intrauterine exposure to hyper- or hypocalcemia may impact their postnatal regulation of calcium metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Bone Quality Leiden University Medical Center: Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
- Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.
ORCID-Profile: Natasha M Appelman-Dijkstra, Stefan Pilz
Zitieren
APA
Appelman-Dijkstra, N. M., & Pilz, S. (2023). Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgac734
Vancouver
Appelman-Dijkstra NM, Pilz S. Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgac734
BibTeX
@article{AppelmanDijkstra2023,
author = {Appelman-Dijkstra, Natasha M and Pilz, Stefan},
title = {Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgac734}
}
EUVIMED